These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22784017)

  • 21. Analgesia with Gabapentin and Pregabalin May Involve
    Taylor CP; Harris EW
    J Pharmacol Exp Ther; 2020 Jul; 374(1):161-174. PubMed ID: 32321743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators.
    Stahl SM
    J Clin Psychiatry; 2004 Aug; 65(8):1033-4. PubMed ID: 15323585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity.
    Field MJ; Oles RJ; Singh L
    Br J Pharmacol; 2001 Jan; 132(1):1-4. PubMed ID: 11156553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.
    Roth T; Arnold LM; Garcia-Borreguero D; Resnick M; Clair AG
    Sleep Med Rev; 2014 Jun; 18(3):261-71. PubMed ID: 24119681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
    Nymdelger S; Nieber K
    Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain.
    Rahman W; Bauer CS; Bannister K; Vonsy JL; Dolphin AC; Dickenson AH
    Mol Pain; 2009 Aug; 5():45. PubMed ID: 19664204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview.
    Martinotti G; Lupi M; Sarchione F; Santacroce R; Salone A; De Berardis D; Serroni N; Cavuto M; Signorelli M; Aguglia E; Valchera A; Iasevoli F; Di Giannantonio M
    Curr Pharm Des; 2013; 19(35):6367-74. PubMed ID: 23782139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing.
    Pohl RB; Feltner DE; Fieve RR; Pande AC
    J Clin Psychopharmacol; 2005 Apr; 25(2):151-8. PubMed ID: 15738746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
    Micheva KD; Taylor CP; Smith SJ
    Mol Pharmacol; 2006 Aug; 70(2):467-76. PubMed ID: 16641316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?
    Stahl SM; Porreca F; Taylor CP; Cheung R; Thorpe AJ; Clair A
    Trends Pharmacol Sci; 2013 Jun; 34(6):332-9. PubMed ID: 23642658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pregabalin (Lyrica)].
    Ide Y
    Masui; 2013 Jul; 62(7):808-13. PubMed ID: 23905403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats.
    McClelland D; Evans RM; Barkworth L; Martin DJ; Scott RH
    BMC Pharmacol; 2004 Aug; 4():14. PubMed ID: 15294026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pregabalin and postoperative hyperalgesia. A review].
    Lederer AJ; Bornemann-Cimenti H; Wejbora M; Kern-Pirsch C; Michaeli K; Sandner-Kiesling A
    Schmerz; 2011 Feb; 25(1):12-8. PubMed ID: 21181417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation of K(+)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin.
    Brawek B; Löffler M; Dooley DJ; Weyerbrock A; Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jan; 376(5):301-7. PubMed ID: 18074120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central sensitization and Ca(V)α₂δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect.
    Tuchman M; Barrett JA; Donevan S; Hedberg TG; Taylor CP
    J Pain; 2010 Dec; 11(12):1241-9. PubMed ID: 20472509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology and Mechanism of Action of HSK16149, a Selective Ligand of
    Gou X; Yu X; Bai D; Tan B; Cao P; Qian M; Zheng X; Chen L; Shi Z; Li Y; Ye F; Liang Y; Ni J
    J Pharmacol Exp Ther; 2021 Mar; 376(3):330-337. PubMed ID: 33293377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregabalin for the treatment of generalized anxiety disorder: an update.
    Baldwin DS; Ajel K; Masdrakis VG; Nowak M; Rafiq R
    Neuropsychiatr Dis Treat; 2013; 9():883-92. PubMed ID: 23836974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute modulation of calcium currents and synaptic transmission by gabapentinoids.
    Uchitel OD; Di Guilmi MN; Urbano FJ; Gonzalez-Inchauspe C
    Channels (Austin); 2010; 4(6):490-6. PubMed ID: 21150315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate.
    Kumar N; Laferriere A; Yu JS; Leavitt A; Coderre TJ
    J Neurochem; 2010 Apr; 113(2):552-61. PubMed ID: 20132471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.